Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 4/1999

01-04-1999

Trypsinogen Activation Peptides (TAP) in Peritoneal Fluid as Predictors of Late Histopathologic Injury in Necrotizing Pancreatitis of the Rat

Authors: Jan Schmidt, Eduard Ryschich, Hans P. Sinn, Sasa Maksan, Christian Herfarth, Ernst Klar

Published in: Digestive Diseases and Sciences | Issue 4/1999

Login to get access
Metadata
Title
Trypsinogen Activation Peptides (TAP) in Peritoneal Fluid as Predictors of Late Histopathologic Injury in Necrotizing Pancreatitis of the Rat
Authors
Jan Schmidt
Eduard Ryschich
Hans P. Sinn
Sasa Maksan
Christian Herfarth
Ernst Klar
Publication date
01-04-1999
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
Digestive Diseases and Sciences / Issue 4/1999
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1023/A:1026638614855

Other articles of this Issue 4/1999

Digestive Diseases and Sciences 4/1999 Go to the issue

News

News and Notices

OriginalPaper

Intra-and Extrahepatic Leukocytes and Cytokine mRNA Expression During Liver Regeneration After Partial Hepatectomy in Rats

OriginalPaper

Assessment of Gastric Emptying (Comparison of Solid Scintigraphic Emptying and Emptying of Radiopaque Markers in Patients and Healthy Subjects)

OriginalPaper

Effect of Dehydroleucodine on Mucus Production (A Quantitative Study)

OriginalPaper

Evaluation of Hepatic Function in Liver Cirrhosis (Clinical Utility of Galactose Elimination Capacity, Hepatic Clearance of D-Sorbitol, and Laboratory Investigations)

OriginalPaper

Local and Systemic Liberation of Proinflammatory Cytokines in Ulcerative Colitis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits